HUTCHMED Announces Appointment of Acting Chief Executive Officer - HUTCHMED (China) (NASDAQ:HCM)

HUTCHMED Announces Appointment of Acting Chief Executive Officer - HUTCHMED (China) (NASDAQ:HCM)

HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his duties as Chief Executive Officer due to health reasons. In light of this, the Board of Directors has appointed Mr Johnny Cheng, an Executive Director and Chief Financial Officer of the Compan…

HUTCHMED Announces Appointment of Acting Chief Executive Officer

Open the article to view the coverage from TecHR

Global Biotech HUTCHMED Announces Leadership Change: CFO Johnny Cheng Steps Up as Acting CEO

HUTCHMED's CFO Johnny Cheng assumes Acting CEO role as Dr. Weiguo Su takes health-related leave. Board confirms research, development and commercial initiatives remain on track.